Logo

PierianDx: Lindsay Mateo

Mar 05, 2021

PierianDx, which specializes in cancer informatics for diagnostics and targeted therapies, has appointed Lindsay Mateo as chief business officer. Mateo previously served as head of commercial operations and later as vice president and head of life sciences at Tempus. She has also led commercial teams at Navican, an Intermountain Healthcare Company; and Genoptix, now part of NeoGenomics.

Breaking News
The Scan

Sick Newborns Selected for WGS With Automated Pipeline

Researchers successfully prioritized infants with potential Mendelian conditions for whole-genome sequencing or rapid whole-genome sequencing, as they report in Genome Medicine.

Acne-Linked Loci Found Through GWAS Meta-Analysis

Researchers in EJHG find new and known acne vulgaris risk loci with a genome-wide association study and meta-analysis, highlighting hair follicle- and metabolic disease-related genes.

Retina Cell Loss Reversed by Prime Editing in Mouse Model of Retinitis Pigmentosa

A team from China turns to prime editing to correct a retinitis pigmentosa-causing mutation in the PDE6b gene in a mouse model of the progressive photoreceptor loss condition in the Journal of Experimental Medicine.

CRISPR Screens Reveal Heart Attack-Linked Gene

Researchers in PLOS Genetics have used CRISPR screens to home in on variants associated with coronary artery disease that affect vascular endothelial function.